Safety
ADVERSE EVENTS
Both presentations of the ID93 + GLA-SE vaccine were determined to be safe and well tolerated in healthy adult participants following intramuscular (IM) administration. The pattern, type, severity, and frequency of adverse events (AEs) were similar across both treatment groups. Table Subjects with adverse events occurring in >5% of the safety population